Flora Luo

986 total citations
9 papers, 390 citations indexed

About

Flora Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Flora Luo has authored 9 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Flora Luo's work include Melanoma and MAPK Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Mechanisms and Therapy (2 papers). Flora Luo is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Mechanisms and Therapy (2 papers). Flora Luo collaborates with scholars based in United States and United Kingdom. Flora Luo's co-authors include Levi A. Garraway, Martin Decaris, Kelvin W. Li, Michelle Gatmaitan, Scott Turner, Marc K. Hellerstein, Claire Emson, William E. Holmes, David E. Root and Mahmoud Ghandi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Flora Luo

9 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Flora Luo United States	7	205	103	100	62	47	9	390
Catherine Geh United Kingdom	7	231 1.1×	123 1.2×	189 1.9×	59 1.0×	80 1.7×	7	511
Jürgen Stahl Australia	10	216 1.1×	85 0.8×	87 0.9×	40 0.6×	75 1.6×	20	364
Qing-Rong Chen United States	9	289 1.4×	140 1.4×	105 1.1×	54 0.9×	93 2.0×	9	484
Alexander C. Jordan United States	7	307 1.5×	60 0.6×	134 1.3×	36 0.6×	87 1.9×	10	453
Devin Worster United States	4	255 1.2×	50 0.5×	153 1.5×	35 0.6×	55 1.2×	6	410
Katie Kane United Kingdom	6	363 1.8×	101 1.0×	256 2.6×	77 1.2×	46 1.0×	9	531
Luigi Alfano Italy	11	271 1.3×	56 0.5×	95 0.9×	26 0.4×	45 1.0×	23	396
K. Papadopoulos United States	11	236 1.2×	136 1.3×	198 2.0×	62 1.0×	66 1.4×	46	462
Jenny Han United States	9	218 1.1×	81 0.8×	61 0.6×	23 0.4×	67 1.4×	21	352
Tao Osgood United States	6	158 0.8×	58 0.6×	185 1.9×	32 0.5×	43 0.9×	14	308

Countries citing papers authored by Flora Luo

Since Specialization

Citations

This map shows the geographic impact of Flora Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Luo more than expected).

Fields of papers citing papers by Flora Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Luo. The network helps show where Flora Luo may publish in the future.

Co-authorship network of co-authors of Flora Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Luo. A scholar is included among the top collaborators of Flora Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Luo. Flora Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Wander, Seth A., Ofir Cohen, Gabriela N. Johnson, et al.. (2020). Abstract B23: Genomic sequencing of metastatic hormone-receptor positive breast cancer implicates AKT1 in driving resistance to cyclin-dependent kinase 4/6 inhibitors. Molecular Cancer Research. 18(10_Supplement). B23–B23. 1 indexed citations

Hayes, Tikvah K., Flora Luo, Ofir Cohen, et al.. (2019). A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant Melanoma. Cancer Research. 79(9). 2352–2366. 30 indexed citations

Wander, Seth A., Ofir Cohen, Gabriela N. Johnson, et al.. (2018). Whole exome sequencing (WES) in hormone-receptor positive (HR+) metastatic breast cancer (MBC) to identify mediators of resistance to cyclin-dependent kinase 4/6 inhibitors (CDK4/6i).. Journal of Clinical Oncology. 36(15_suppl). 12016–12016. 11 indexed citations

Le, Xiuning, Pedram Razavi, Daniel J. Treacy, et al.. (2016). Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer. Cancer Discovery. 6(10). 1134–1147. 97 indexed citations

Whittaker, Steven R., Glenn S. Cowley, Steve Wagner, et al.. (2015). Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors. Molecular Cancer Therapeutics. 14(12). 2700–2711. 55 indexed citations

Decaris, Martin, Claire Emson, Kelvin W. Li, et al.. (2015). Turnover Rates of Hepatic Collagen and Circulating Collagen-Associated Proteins in Humans with Chronic Liver Disease. PLoS ONE. 10(4). e0123311–e0123311. 45 indexed citations

Decaris, Martin, Michelle Gatmaitan, Flora Luo, et al.. (2014). Proteomic Analysis of Altered Extracellular Matrix Turnover in Bleomycin-induced Pulmonary Fibrosis. Molecular & Cellular Proteomics. 13(7). 1741–1752. 106 indexed citations

Luo, Flora & Levi A. Garraway. (2014). Abstract 3431: Functional characterization of ARID2 in melanoma and melanocytes. Cancer Research. 74(19_Supplement). 3431–3431. 1 indexed citations

Byrne, Shaina L., Peter D. Buckett, Jonghan Kim, et al.. (2013). Ferristatin II Promotes Degradation of Transferrin Receptor-1 In Vitro and In Vivo. PLoS ONE. 8(7). e70199–e70199. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact